Both in Biotechnology
X4 Pharmaceuticals vs Eikon Therapeutics
Over the past year XFOR returned −11.5% and EIKN returned −57.4%; their daily moves had a correlation of 0.28.
XFOR −11.5% EIKN −57.4%Growth of $1, one year, split-adjusted
| Metric | XFOR | EIKN |
|---|---|---|
| Price | $3.24 | $6.39 |
| Market cap | $321.2M | $346.1M |
| Today | +2.21% | +15.14% |
| 1 month | +17.0% | −14.9% |
| 6 months | −26.0% | −35.9% |
| Year to date | −19.0% | — |
| 1 year | −20.8% | — |
| Revenue growth (YoY) | +346.3% | — |
| Gross margin | 81.6% | — |
| Net margin | −183.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 20.3× | — |
| Net cash | $131.2M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 103.8% |
| Short % of float | 9.3% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).